489460 — Biobijou Co Income Statement
0.000.00%
Last trade - 00:00- KR₩104bn
- KR₩83bn
- KR₩28bn
Annual income statement for Biobijou Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 17,130 | 29,633 | 28,491 |
| Cost of Revenue | |||
| Gross Profit | 8,274 | 14,852 | 15,921 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Depreciation and Amortization | |||
| Total Operating Expenses | 11,966 | 20,406 | 24,264 |
| Operating Profit | 5,165 | 9,227 | 4,227 |
| Gain / Loss on Sale of Assets | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 4,227 | 8,979 | 4,999 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 3,310 | 7,188 | 4,152 |
| Minority Interest | |||
| Net Income Before Extraordinary Items | |||
| Net Income | 3,310 | 7,188 | 4,152 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 3,310 | 7,188 | 4,152 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 220 | 478 | 298 |
| Dividends per Share |